127 results
Page 4 of 7
8-K
EX-99.1
mksy5eqaj
2 Mar 20
FibroGen Reports Fourth Quarter and Full Year 2019 Financial Results
4:06pm
CORRESP
xihqyf0i4b
31 Jan 20
Correspondence with SEC
12:00am
8-K
EX-99.1
36qj9kimsm hv9tf
13 Jan 20
Regulation FD Disclosure
9:01am
8-K
EX-99.1
26r uq54d96u
2 Dec 19
FibroGen Announces Roxadustat Inclusion in China’s National Reimbursement Drug List
7:10am
8-K
EX-99.1
lku36l bw0h2ga
12 Nov 19
FibroGen Reports Third Quarter 2019 Financial Results
8:16am
8-K
EX-99.2
yc7ifpv7
12 Nov 19
FibroGen Reports Third Quarter 2019 Financial Results
8:16am
8-K
EX-99.1
6gwlec5s1i9sdlp1xp
8 Aug 19
Fibrogen Reports Second Quarter 2019 Financial Results
4:15pm
8-K
EX-99.1
sz3jsc 0fcnzg
24 Jul 19
Other Events
9:46pm
8-K
EX-99.1
spx458zxopq xzy8
9 May 19
Fibrogen Reports First Quarter 2019 Financial Results
4:15pm
DEFA14A
80beao
23 Apr 19
Additional proxy soliciting materials
4:15pm
8-K
EX-99.1
930snh bi6cwk8dz22
27 Feb 19
Fibrogen Reports Fourth Quarter and Full Year 2018 Financial Results
12:00am
8-K
EX-99.1
zarnzk3w ciiehx4z
7 Jan 19
Regulation FD Disclosure
8:52am
8-K
EX-99.1
1giqtxeany5
20 Dec 18
FibroGen Announces Positive Topline Results from Three Global Phase 3
8:30am